Core Viewpoint - The company Yiduoli (300381.SZ) is advancing its R-PET enzyme project, which aims to biologically degrade waste plastics and fabrics, thereby significantly reducing plastic pollution and carbon footprint in line with carbon neutrality goals [1] Group 1 - The R-PET enzyme has completed strain construction and small-scale testing, and is progressing according to the established plan [1] - The company is continuously optimizing the performance of recombinant strains and enzymes while exploring pre-treatment and degradation processes for waste plastics [1] - The product is expected to have a strong market outlook due to its potential to recycle waste materials into regenerated resources [1]

Core Viewpoint - Yidoli's stock price has shown fluctuations with a recent decline, while the company has experienced mixed financial performance in terms of revenue and net profit [1][2]. Group 1: Stock Performance - As of January 16, Yidoli's stock price decreased by 2.13%, trading at 6.89 CNY per share with a total market capitalization of 3.383 billion CNY [1]. - Year-to-date, Yidoli's stock has increased by 5.67%, with a 1.62% rise over the last five trading days and an 8.85% increase over the last 20 days, while it has seen a slight decline of 0.72% over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Yidoli reported a revenue of 613 million CNY, reflecting a year-on-year growth of 0.77%, while the net profit attributable to shareholders was 18.204 million CNY, which represents a significant decrease of 57.47% compared to the previous year [2]. - Since its A-share listing, Yidoli has distributed a total of 359 million CNY in dividends, with 125 million CNY distributed over the last three years [3]. Group 3: Company Overview - Yidoli, established on September 3, 1991, and listed on January 28, 2014, is located in Zhuhai, Guangdong Province, and specializes in the research, production, and sales of biological enzyme preparations, steroid hormone raw materials, plant extracts, and animal nutrition products [2]. - The company's main business revenue composition includes biological enzyme preparations (83.94%), plant extracts (8.34%), feed and feed additives (6.78%), and other products (0.95%) [2]. - Yidoli is classified under the pharmaceutical and biological industry, specifically in the chemical pharmaceutical and raw material drug sectors, and is associated with concepts such as raw materials, vitamins, small-cap stocks, biological manufacturing, and synthetic biology [2].

证券日报网讯1月14日，溢多利（300381）在互动平台回答投资者提问时表示，由于下游洗涤剂行业产 品种类较多，配方较为复杂，包括但不限于颗粒、粉剂、液体等剂型，功效包括去污、护理、防串色 等，所以洗涤酶产品研发和验证周期相对较长。公司洗涤酶产品自上市以来，持续与各类日化企业开展 合作与应用实验，逐步得到客户认可，实现国产替代。公司一直重视洗涤酶产品的研发和销售，不断加 大投入，优化营销队伍建设，丰富产品种类，从剂型到功效再到产品性能，都在逐步提升和完善。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 广东溢多利生物科技股份有限公司（以下简称"公司"）于 2026 年 1 月 5 日接到控股股东珠海市金大地投资有限公司（以下简称"金大地投资"）的 通知，金大地投资将其所持有的本公司部分股份办理了质押展期手续，具体事 项如下： 广东溢多利生物科技股份有限公司 关于控股股东部分股份质押展期的公告 股票代码：300381 股票简称：溢多利 公告编号：2026-001 特此公告。 | 股东 | 是否为 第一大 股东及 | 本次质押 股数 | 占其所 持股份 | 占公司总 股本比例 | 是否为 | 是否为 补充质 | 质押 | | 原质押 | | 展期后质 | | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 一致行 | （万股） | 比例 | （%） | 限售股 | 押 | 起始日 | | 到期日 | | 押到期日 | | | 用途 | | | | ...

Group 1: Overseas Market Development - Arrow Home has been focusing on internationalization, increasing strategic investment in overseas markets, and establishing partnerships with local distributors to expand its sales network, resulting in significant revenue growth outside North America, although overall overseas revenue has declined due to changes in the international economic environment [2] - Yiduoli has been enhancing its overseas market presence, with product registrations completed in over 30 countries and regions, and plans to establish a subsidiary in Brazil to strengthen sales coverage in Latin America [3] - Companies like Boying Welding and Jereh have also reported significant progress in their international strategies, with Boying Welding investing in a production base in Vietnam and Jereh expanding its overseas business to over 70 countries [4] Group 2: New Year Development Plans - Wave Optoelectronics plans to focus on semiconductor and laser businesses, aiming for steady growth and expansion into new application areas while maintaining core competitiveness [5] - Arrow Home intends to enhance retail channel management and promote new products in collaboration with Hongmeng Smart Selection, aiming for broader coverage and efficiency in 2026 [5] - Changbao Co. expects to maintain a favorable market for boiler pipes and will focus on high-end product promotion and structural upgrades [7] Group 3: AI Development - Shenzhen Huaqiang emphasizes that AI is a core driver for growth in electronic components, with increasing demand in AI servers and data centers [8] - Zhongdian Port reported a significant increase in AI-related revenue, reaching 9.309 billion yuan in the first three quarters of 2025, reflecting a 78.3% year-on-year growth [9] - Companies like Hanwei Technology are actively integrating AI into their product offerings, developing multi-dimensional sensor systems for intelligent robotics [8][9]

Group 1 - The company currently engages in NMN business by providing raw material processing for clients [1]

格隆汇12月24日丨溢多利(300381.SZ)在投资者关系中表示，有被问到:公司新增了一些生产基地建设等 资本开支，大概在什么时候资本开支的高峰期会过去？ 答：公司去年研发中心升级扩建、金湾基地投产转固增加了部分资本开支，目前在建的还有内蒙古酶制 剂三期工程及珠海总部科创园建设等项目，这些项目投产后预计短期内将不会再有新增的大额资本开 支。 ...

Group 1 - The core viewpoint of the article is that Yiduoli (300381) is currently engaged in contract manufacturing for its NMN business, providing raw materials for clients [1] Group 2 - The company responded to inquiries from researchers on December 23, indicating its current operational focus [1]

Core Viewpoint - Yiduoli (300381) reported an increase in sales and gross margin for its electroplating hydrogen peroxide enzyme product, which is primarily used in the cleaning process of electronic product manufacturing, although its overall revenue contribution remains small [1] Group 1 - The electroplating hydrogen peroxide enzyme is designed to remove hydrogen peroxide residues from material surfaces during the production of electronic products [1] - The product has been on the market since last year, and improvements in strain research and product performance have contributed to the increase in sales and gross margin in the first three quarters of this year compared to last year [1] - Despite the improvements, the overall revenue contribution of this product remains relatively low [1]

（编辑 姚尧） 证券日报网12月24日讯 ，溢多利在12月23日回答调研者提问时表示，去年公司的研发费用和财务费用 有所增长，主要是由于公司升级研发中心，不断加大研发投入和新技术、新产品储备，以及对老产品进 行提升优化；财务费用的增长是由于资本支出的增加导致自有资金利息收入下降；另外今年前三季度， 为加快海外市场拓展，销售费用略有增长。 ...